ERSP advises Lunada Biomedical to discontinue weight-loss claims for supplement Amberen
The Electronic Retailing Self-Regulation Program on Monday recommended that Lunada Biomedical discontinue weight-loss and other claims made for Amberen, a dietary supplement marketed to menopausal women.
Want to Read More?
This content is available only to registered users. Log in to read the rest of this article or create a free account.